Skip to main content
NIH funding notice PA-18-678

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Closed on May 7, 2021.

Posted
February 23, 2018
Close date
May 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $268,287 in first-year total cost, median $268,287.

Most frequent study sections

  1. Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]1

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL1
Competing awards under PA-18-678 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Proteomics Study of Non-viral Related Hepatocellular Carcinoma Risk1R21CA238651-01A1ZHANG, XUEHONGBRIGHAM AND WOMEN'S HOSPITAL, MA$268,287CHSA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.